FDA approved and authorized the 2024-2025 mRNA COVID-19 vaccines on August 22, 2024. FDA authorized Novavax COVID-19 Vaccine, Adjuvanted (2024 – 2025 Formula) under Emergency Use Authorization on August 30, 2024. Learn how you can stay up to date with your COVID-19 vaccine: Staying Up to Date with COVID-19 Vaccines

COVID-19 Vaccines

Purpose

  • Learn about COVID-19 vaccine recommendations, what to expect when getting a vaccine, and vaccine effectiveness.

Resources